Demographic Features, Etiology Trend and Clinical Characteristics of Chronic Pancreatitis: A Respective Study of 346 Cases in Peking Union Medical College Hospital
-
摘要:
目的 探讨慢性胰腺炎(chronic pancreatitis, CP)的人口学特征、发病病因变迁和临床特点 目的 回顾性分析1983年1月至2008年12月北京协和医院346例CP住院患者的资料, 总结其人口学特征、临床表现、病因和并发症情况 结果 346例CP患者中, 男267例, 女79例, 男:女比例为3.38:1, 发病年龄(44.34±15.88)岁。民族分布以汉族为最多(94.80%, 328/346), 职业分布以干部为最多(32.08%, 111/346)。CP患者无论是患者总数还是入院人数占同期住院患者人数的比例均呈现快速增长的趋势。酒精(40.17%)和胆石症(41.04%)是最常见的CP病因因素。不同病因类型的CP均有明显的增长, 以酒精性CP增长尤为显著, 平均年增长率为108.7%。84.39%(292/346)的患者有腹痛症状, 56.07%(194/346)的患者有体重下降, 24.86%(86/346)的患者有黄疸, 均为梗阻性黄疸。CP并发症以糖尿病最为多见, 占25.14%(87/346)。糖尿病和脂肪泻出现的病程中位时间分别在发病后1.00年和280.03个月, 自身免疫性胰腺炎出现糖尿病早于特发性胰腺炎(P=0.020) 结论 我国CP发病人数在快速增长, 酒精性CP的增长速度超过胆源性CP。腹痛与消瘦是CP最常见症状, 糖尿病是CP最常见并发症。建立CP病例资料库并进行有序随诊将有助于总结CP流行病学规律和提高诊治经验。 Abstract:Objective To investigate the demographic features, etiology and clinical characteristics of chronic pancreatitis (CP). Methods We retrospectively analyzed the records of 346 CP cases hospitalized in Peking Union Medical College Hospital during the period of January 1983 to December 2008, summarizing the demographic features, clinical manifestations, causes of disease, and complications of these patients. Results The 346 CP cases included 267 males and 79 females (M/F ratio=3.38:1). The mean age of onset was (44.34±15.88) years. Most of the patients were Han Chinese (94.80%, 328/346), and a large proportion were cadres (32.08%, 111/346). Both the number of CP cases and its proportion in the total number of inpatients in the hospital increased rapidly. Alcohol (40.17%) and cholelithiasis (41.04%) were the most common risk factors of CP. CP of different etiologies had all increased, especially alcoholic CP, growing by an mean annual rate of 108.7%. 84.39%(292/346) of the patients presented with abdominal pain, 56.07% (194/346) had weight loss, 24.86% (86/346)had jaundice (all obstructive). Diabetes (25.14%, 87/346) was the most common complication. The median time of CP onset to occurrence of diabetes and fatty diarrhea were 1.00 year and 280.03 months, respectively. Diabetes occurred earlier in patients with autoimmune pancreatitis than those with idiopathic pancreatitis (P=0.020). Conclusions The incidence of CP is growing rapidly in China, with alcoholic CP increasing faster than biliary CP. The most common symptoms of CP are abdominal pain and weight loss, while the most common complication is diabetes. A patient database and regular follow-up visits could contribute to better understanding of epidemiological patterns of CP and improvement of its diagnosis and treatment. -
表 1 慢性胰腺炎不同病因类型随年代的变化
病因 年份[例(%)] 总计
[例(%)]平均年增长率
(%)1983—1987 1988—1992 1993—1997 1998—2002 2003—2008 胆源性 6(37.5) 8(42.1) 14(32.6) 28(30.4) 58(33.0) 114(32.95) 78.9 酒精性 4(25.0) 8(42.1) 8(18.6) 29(31.5) 50(28.4) 99(28.61) 108.7 自身免疫 0(0) 0(0) 0(0) 4(4.3) 18(10.2) 22(6.36) 350.0 其他 6(37.5) 3(15.8) 21(48.8) 31(33.7) 50(28.4) 111(32.08) 164.7 总计 16(100) 19(100) 43(100) 92(100) 176(100) 346(100) 87.6 -
[1] Garg PK, Tandon RK. Survey on chronic pancreatitis in the Asia-Pacific region[J]. J Gastroenterol Hepatol, 2004, 19:998-1004. doi: 10.1111/j.1440-1746.2004.03426.x [2] Conwell DL, Banks PA. Chronic pancreatitis[J]. Curr Opin Gastroenterol, 2008, 24:586-590. doi: 10.1097/MOG.0b013e32830b10fb [3] Ahmed SA, Wray C, Rilo HL, et al. Chronic pancreatitis:recent advances and ongoing challenges[J]. Curr Probl Surg, 2006, 43:127-238. doi: 10.1067/j.cpsurg.2005.12.004 [4] Andren-Sandberg A, Hardt PD. Second Giessen International Workshop on Interactions of Exocrine and Endocrine Pancreatic Diseases[J]. JOP, 2008, 9:541-575. http://europepmc.org/abstract/med/18648151 [5] Hirota M, Shimosegawa T, Masamune A, et al. The seventh nationwide epidemiological survey for chronic pancreatitis in Japan:clinical significance of smoking habit in Japanese patients[J]. Pancreatology, 2014, 14:490-496. doi: 10.1016/j.pan.2014.08.008 [6] Lin Y, Tamakoshi A, Matsuno S, et al. Nationwide epidemiological survey of chronic pancreatitis in Japan[J]. J Gastroenterol, 2000, 35:136-141. doi: 10.1007/s005350050026 [7] Wang LW, Li ZS, Li SD, et al. Prevalence and clinical features of chronic pancreatitis in China:a retrospective multicenter analysis over 10 years[J]. Pancreas, 2009, 38:248-254. doi: 10.1097/MPA.0b013e31818f6ac1 [8] 周志超, 傅国庆, 潘国忠, 等.我国慢性胰腺炎的临床特点——附132例分析[J].临床消化杂志, 1990, 4:149-152. [9] 陈浮, 李兆申, 王洛伟, 等.慢性胰腺炎的相关因素及诊治分析[J].中华消化杂志, 2006, 28:515-518. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zhxhzz200608004 [10] 肖南平, 欧阳钦.慢性胰腺炎303例的临床分析[J].四川医学, 2008, 129:1510-1513. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=scyx200811026 [11] Lankisch PG. Chronic pancreatitis[J]. Curr Opin Gastroenterol, 2007, 23:502-507. doi: 10.1097/MOG.0b013e3282ba5736 [12] Kaila B, Raman M. Obesity:a review of pathogenesis and management strategies[J]. Can J Gastroenterol, 2008, 22:61-68. doi: 10.1155/2008/609039 [13] Balakrishnan V, Unnikrishnan AG, Thomas V, et al. Chronic pancreatitis. A prospective nationwide study of 1086 subjects from India[J]. JOP, 2008, 9:593-600. http://europepmc.org/abstract/med/18762690 [14] 钱家鸣.慢性胰腺炎的病因[J].胃肠病学, 2001, 6:173-174. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=wcbx200103015 [15] Pongprasobchai S, Manatsathit S. Natural course of abdominal pain in chronic pancreatitis with intermittent (type A) pain after conservative treatment[J]. J Med Assoc Thai, 2009, 92:S43-S48. [16] Anaparthy R, Pasricha PJ. Pain and chronic pancreatitis:is it the plumbing or the wiring?[J]. Curr Gastroenterol Rep, 2008, 10:101-106. doi: 10.1007/s11894-008-0029-4 [17] Fregni F, Pascual-Leone A, Freedman SD. Pain in chronic pancreatitis:a salutogenic mechanism or a maladaptive brain response?[J]. Pancreatology, 2007, 7:411-422. doi: 10.1159/000108958 [18] Gardner TB, Janec EM, Gordon SR. Relationship between patient symptoms and endosonographic findings in chronic pancreatitis[J]. Pancreatology, 2009, 9:398-403. doi: 10.1159/000181178 [19] Waljee AK, Dimagno MJ, Wu BU, et al. Systematic review:pancreatic enzyme treatment of malabsorption associated with chronic pancreatitis[J]. Aliment Pharmacol Ther, 2009, 29:235-246. doi: 10.1111/j.1365-2036.2008.03885.x [20] Liu D, Cao L, Yu J, et al. Diagnosis of pancreatic adenocarcinoma using protein chip technology[J]. Pancreatology, 2009, 9:127-135. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=06818b4d1f3675bcba82084cf975494e [21] Das A, Nguyen CC, Li F, et al. Digital image analysis of EUS images accurately differentiates pancreatic cancer from chronic pancreatitis and normal tissue[J]. Gastrointest Endosc, 2008, 67:861-867. doi: 10.1016/j.gie.2007.08.036 [22] Fang F, He X, Deng H, et al. Discrimination of metabolic profiles of pancreatic cancer from chronic pancreatitis by high-resolution magic angle spinning 1H nuclear magnetic resonance and principal components analysis[J]. Cancer Sci, 2007, 98:1678-1682. doi: 10.1111/j.1349-7006.2007.00589.x [23] Chang MC, Chang YT, Su TC, et al. Adiponectin as a potential differential marker to distinguish pancreatic cancer and chronic pancreatitis[J]. Pancreas, 2007, 35:16-21. doi: 10.1097/MPA.0b013e3180547709 [24] Talar-Wojnarowska R, Gasiorowska A, Smolarz B, et al. Usefulness of p16 and K-ras mutation in pancreatic adenocarcinoma and chronic pancreatitis differential diagnosis[J]. J Physiol Pharmacol, 2004, 55 Suppl 2:129-138. http://www.ncbi.nlm.nih.gov/pubmed/15608367 [25] Chan A, Prassas I, Dimitromanolakis A, et al. Validation of biomarkers that complement CA19.9 in detecting early pancreatic cancer[J]. Clin Cancer Res, 2014, 20:5787-5795. doi: 10.1158/1078-0432.CCR-14-0289 [26] Lee MJ, Na K, Jeong SK, et al. Identification of human complement factor B as a novel biomarker candidate for pancreatic ductal adenocarcinoma[J]. J Proteome Res, 2014, 13:4878-4888. doi: 10.1021/pr5002719 [27] Wilcox CM, Varadarajulu S. Endoscopic therapy for chronic pancreatitis:an evidence-based review[J]. Curr Gastroenterol Rep, 2006, 8:104-110. doi: 10.1007/s11894-006-0005-9 [28] DiMagno MJ, Dimagno EP. Chronic pancreatitis[J]. Curr Opin Gastroenterol, 2006, 22:487-497. [29] Molero Richard X. Chronic pancreatitis[J]. Gastroenterol Hepatol, 2008, 31 Suppl 4:76-82. [30] Otsuki M. Chronic pancreatitis in Japan:epidemiology, prognosis, diagnostic criteria, and future problems[J]. J Gastroenterol, 2003, 38:315-326. doi: 10.1007/s005350300058 [31] Lee DK. Natural course and medical treatment of chronic pancreatitis[J]. Korean J Gastroenterol, 2005, 46:345-351. http://europepmc.org/abstract/med/16301847 [32] Pezzilli R, Morselli Labate AM, Fantini L, et al. Quality of life and clinical indicators for chronic pancreatitis patients in a 2-year follow-up study[J]. Pancreas, 2007, 34:191-196. doi: 10.1097/mpa.0b013e31802e0301 [33] Sandhu BS, Hackworth WA, Stevens S, et al. Recurrent flares of pancreatitis predict development of exocrine insufficiency in chronic pancreatitis[J]. Clin Gastroenterol Hepatol, 2007, 5:1085-1091. doi: 10.1016/j.cgh.2007.04.011 [34] Hirano K, Saito T, Mizuno S, et al. Total cholesterol level for assessing pancreatic insufficiency due to chronic pancreatitis[J]. Gut Liver, 2014, 8:563-568. doi: 10.5009/gnl13366 [35] Andersen DK, Andren-Sandberg A, Duell EJ, et al. Pancreatitis-diabetes-pancreatic cancer:summary of an NIDDK-NCI workshop[J]. Pancreas, 2013, 42:1227-1237. doi: 10.1097/MPA.0b013e3182a9ad9d